Rheumatoid Arthritis Unknown Status Phase 4 Trials for Infliximab (DB00065)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

DBCOND0027961 (Rheumatoid Arthritis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01072058Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF BlockerScreening
NCT00216177Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisTreatment
NCT02132234Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisTreatment
NCT01282528Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid ArthritisTreatment
NCT01000441Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisTreatment